Insmed Inc. buy UBS Group AG
Start price
08.08.25
/
50%
€94.50
Target price
08.08.26
-
Performance (%)
19.79%
End price
09.08.26
€113.20
Summary
This prediction ended on 09.08.26 with a price of €113.20. The prediction had a final performance of 19.79%. UBS_Group_AG has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 33.256% | 33.256% | 13.505% |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its "buy" rating re-affirmed by analysts at UBS Group AG.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten